NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
80 hedge funds and large institutions have $56.5M invested in Northwest Biotherapeutics, Inc. Common stock in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less call options, than puts
Call options by funds: $4.9M | Put options by funds: $5.57M
Holders
80
Holding in Top 10
1
Calls
$4.9M
Puts
$5.57M
Top Buyers
| 1 | +$5.3M | |
| 2 | +$2.41M | |
| 3 | +$2.12M | |
| 4 |
Goldman Sachs
New York
|
+$1.56M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$1.24M |
Top Sellers
| 1 | -$9.58M | |
| 2 | -$1.32M | |
| 3 | -$1.01M | |
| 4 |
SFM
Soros Fund Management
New York
|
-$793K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$574K |